Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 907-915 , November 2007

In vivo dynamic imaging of myocardial cell death using 99mTc-labeled C2A domain of synaptotagmin I in a rat model of ischemia and reperfusion

  • Zhonglin Liu

      Affiliations

    • Department of Radiology, University of Arizona, Tucson, AZ 85724, USA
    • Corresponding Author InformationCorresponding author. Department of Radiology, University of Arizona, P.O. Box 245067, Tucson, AZ 85724-5067, USA. Tel.: +1 520 626 4248; fax: +1 520 626 2892.
    • ,
  • Ming Zhao

      Affiliations

    • Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    • ,
  • Xiaoguang Zhu

      Affiliations

    • Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    • ,
  • Lars R. Furenlid

      Affiliations

    • Department of Radiology, University of Arizona, Tucson, AZ 85724, USA
    • ,
  • Yi-Chun Chen

      Affiliations

    • Department of Radiology, University of Arizona, Tucson, AZ 85724, USA
    • ,
  • Harrison H. Barrett

      Affiliations

    • Department of Radiology, University of Arizona, Tucson, AZ 85724, USA

Received 8 May 2007 ,Revised 18 July 2007 ,Accepted 21 July 2007.

References 

  1. Gottlieb RA, Engler RL. Apoptosis in myocardial ischemia–reperfusion. Ann N Y Acad Sci. 1999;874:412–416
  2. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995;146:3–15
  3. Buja LM, Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation. 1998;98:1355–1357
  4. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545–1556
  5. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med. 1995;182:1597–1601
  6. van Heerde WL, Robert-Offerman S, Dumont E, Hofstra L, Doevendans PA, Smits JF, et al. Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiovasc Res. 2000;45:549–559
  7. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med. 1994;123:741–748
  8. Tait JF, Cerqueira MD, Dewhurst TA, Fujikawa K, Ritchie JL, Stratton JR. Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res. 1994;75:491–501
  9. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med. 1999;40:184–191
  10. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349–6354
  11. Kietselaer BL, Reutelingsperger CP, Boersma HH, Heidendal GA, Liem IH, Crijns HJ, et al. Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med. 2007;48:562–567
  12. Sarda-Mantel L, Michel JB, Rouzet F, Martet G, Louedec L, Vanderheyden JL, et al. (99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats. Eur J Nucl Med Mol Imaging. 2006;33:239–245
  13. Mukherjee A, Kothari K, Toth G, Szemenyei E, Sarma HD, Kornyei J, et al. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death. Nucl Med Biol. 2006;33:635–643
  14. Jung HI, Kettunen MI, Davletov B, Brindle KM. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug Chem. 2004;15:983–987
  15. Neves AA, Krishnan AS, Kettunen MI, Hu DE, Backer MM, Davletov B, et al. A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging. Nano Lett. 2007;7:1419–1423
  16. Zhao M, Zhu X, Ji S, Zhou J, Ozker KS, Fang W, et al. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. J Nucl Med. 2006;47:1367–1374
  17. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med. 2001;7:1241–1244
  18. Zhu X, Li Z, Zhao M. Imaging acute cardiac cell death: temporal and spatial distribution of 99mTc-labeled C2A in the area at risk after myocardial ischemia and reperfusion. J Nucl Med. 2007;48:1031–1036
  19. Furenlid LR, Wilson DW, Chen YC, Kim H, Pietraski PJ, Crawford MJ, et al. FastSPECT II: a second-generation high-resolution dynamic SPECT imager. IEEE Trans Nucl Sci. 2004;51:631–635
  20. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest. 1997;100:1813–1821
  21. Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart disease — a novel therapeutic target?. Faseb J. 2002;16:135–146
  22. Otani H, Uchiyama T, Yamamura T, Nakao Y, Hattori R, Ninomiya H, et al. Effects of the Na+/H+ exchange inhibitor cariporide (HOE 642) on cardiac function and cardiomyocyte cell death in rat ischaemic–reperfused heart. Clin Exp Pharmacol Physiol. 2000;27:387–393
  23. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, et al. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene. 1996;12:2045–2050
  24. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis. 2001;6:279–290
  25. Blancke F, Claeys MJ, Jorens P, Vermeiren G, Bosmans J, Wuyts FL, et al. Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediators Inflamm. 2005;2005:385–389
  26. Khaw BA. The current role of infarct avid imaging. Semin Nucl Med. 1999;29:259–270
  27. Khaw BA, Nakazawa A, O'Donnell SM, Pak KY, Narula J. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol. 1997;4:283–290
  28. Liu Z, Barrett HH, Stevenson GD, Kastis GA, Bettan M, Furenlid LR, et al. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. J Nucl Med. 2004;45:1251–1259
  29. Saeed M, van Dijke CF, Mann JS, Wendland MF, Rosenau W, Higgins CB, et al. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging. 1998;8:561–567

PII: S0969-8051(07)00193-X

doi: 10.1016/j.nucmedbio.2007.07.013

Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 907-915 , November 2007

Article Tools

* Image Usage & Resolution